Stock data
Citius Pharmaceuticals, Inc. (CTXR)
Citius Pharmaceuticals, Inc. (CTXR) reported net income of -US$39.74M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-09-30
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$38.53M | -US$39.74M | — |
| 2024 | — | — | -US$42.00M | -US$39.43M | — |
| 2023 | — | — | -US$36.73M | -US$32.54M | — |
| 2022 | — | — | -US$33.32M | -US$33.64M | — |
| 2021 | — | — | -US$23.53M | -US$23.05M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$1.49M | -US$11.92M | — |
| 2026-03-31 | US$1.67M | -US$28.11M | — |
| 2025-12-31 | US$3.94M | -US$9.39M | — |
| 2025-09-30 | — | -US$8.74M | — |
| 2025-06-30 | — | -US$9.20M | — |
| 2025-03-31 | — | -US$11.51M | — |
| 2024-12-31 | — | -US$10.28M | — |
| 2024-09-30 | — | -US$29.54M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.